ORIC (ORIC Pharmaceuticals) Institutional Ownership: 115.11% (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ORIC ORIC Pharmaceuticals Inc ORIC
34 GF Score
Price $13.74
! 4 Warning Signs
View Full Analysis

What is ORIC Pharmaceuticals Institutional Ownership?

ORIC Pharmaceuticals ORIC -1.22% 34 Institutional Ownership is 115.11% as of Aug. 27, 2026. GuruFocus rates ORIC with a GF Score™ of 34/100. The stock has 4 warning signs investors should review.

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, ORIC Pharmaceuticals's institutional ownership is 115.11%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, ORIC Pharmaceuticals's Insider Ownership is 0.88%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, ORIC Pharmaceuticals's Float Percentage Of Total Shares Outstanding is 98.96%.

ORIC Pharmaceuticals Institutional Ownership Historical Data

* Premium members only.

The historical data trend for ORIC Pharmaceuticals's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

ORIC Pharmaceuticals Institutional Ownership Chart

ORIC Pharmaceuticals Historical Data

The historical data trend for ORIC Pharmaceuticals can be seen below:

2025-10-31 2025-11-30 2025-12-31 2026-01-31 2026-02-28 2026-03-31 2026-04-30 2026-05-31 2026-06-30 2026-07-31
Institutional Ownership 33.58 35.09 36.66 38.49 38.61 37.93 37.88 37.91 41.50 42.71
ORIC
34GF Score
ORIC Pharmaceuticals Inc ORIC
Institutional Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

ORIC Pharmaceuticals Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.

What does a Institutional Ownership of 115.11% mean?
ORIC Pharmaceuticals (ORIC) has a Institutional Ownership of 115.11% as of Aug. 27, 2026. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on ORIC Pharmaceuticals and its competitors.
Is ORIC Pharmaceuticals' Institutional Ownership too high?
ORIC Pharmaceuticals' current Institutional Ownership is 115.11%. Overall, ORIC Pharmaceuticals has a GF Score™ of 34/100, reflecting its overall financial health beyond just this single metric.
How does ORIC Pharmaceuticals' Institutional Ownership compare to ARDX and IMTX?
ORIC Pharmaceuticals' Institutional Ownership of 115.11% can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Institutional Ownership for a Biotechnology company?
A good Institutional Ownership depends on the Biotechnology industry context. However, Institutional Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Institutional Ownership mean?
A high Institutional Ownership can signal that a stock is expensive relative to its fundamentals. Institutional ownership equals the percent of shares owned by financial institutions relative to total shares. View historical data on ORIC Pharmaceuticals and its competitors. ORIC Pharmaceuticals's current Institutional Ownership is 115.11%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is ORIC Pharmaceuticals stock overvalued right now?
ORIC Pharmaceuticals (ORIC) has a current Institutional Ownership of 115.11%. The current Institutional Ownership is 115.11%. ORIC Pharmaceuticals' overall GF Score™ is 34/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Institutional Ownership calculated?
Institutional Ownership is calculated from a company's financial statements. For ORIC Pharmaceuticals (ORIC), the current Institutional Ownership is 115.11% as of Aug. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

ORIC Pharmaceuticals Business Description

Other Exchanges 4TZ:Germany
Address 240 E. Grand Avenue, 2nd Floor, South San Francisco, CA, USA, 94080
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.
34GF Score

Get the complete analysis for ORIC

Institutional Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.74
Price